4/A: HeartBeam Director Richard Ferrari Corrects Share Purchase

Director Richard Ferrari filed an amendment to his Form 4 to correct the number of shares acquired in HeartBeam's recent public offering.

Summary

• Director Richard Ferrari acquired 57,500 shares of HeartBeam, Inc. (BEAT) common stock at a price of $0.80 per share.
• The transaction occurred on April 16, 2026, in connection with the company's underwritten public offering.
• This filing serves as an amendment to the original Form 4 filed on April 16, 2026, to correct an inadvertent reporting error.
• The total beneficial ownership for the director is now reported as 286,636 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing; while the insider purchase is positive, the filing is merely a correction of a previous clerical error.

Positives

• Director demonstrates confidence in the company by participating in the public offering.
• The amendment corrects a clerical error, ensuring accurate regulatory reporting.

Negatives

• The initial filing contained an error regarding the number of shares acquired, necessitating an amendment.

Risks

• Reliance on public offerings for capital can lead to shareholder dilution.

Future Outlook

No specific forward-looking guidance provided in this ownership disclosure.

Industry Context

StockSavvy.ai notes that insider participation in public offerings is generally viewed as a positive signal of management alignment with shareholder interests, though this specific filing is primarily administrative in nature.

Comparison to Industry Standards

• Insider participation in capital raises is a standard practice for small-cap biotech and medical device companies to signal confidence to the market.

Stakeholder Impact

• Shareholders benefit from increased transparency regarding insider holdings.

Key Dates

Keywords

HeartBeam, BEAT, Form 4, Insider Trading, Director Purchase, Public Offering